Telehealth has been a necessity throughout the COVID-19 pandemic, and additional remote technology can support a variety of care needs. Mark Foulke, EVP of Transformational Value-Based Care, discusses the future of care management with robust telehealth technology.
A new study from Mercer shows that 47 percent of employers will not engage in healthcare cost-shifting in 2021 despite increasing costs of employer-sponsored health plans. Employers will be shifting the focus of their plans to telehealth services, behavioral health resources, and voluntary benefits.
A recent study found that practices can recoup the cost of adding a medical scribe service, which may reduce burnout, within the first year by seeing more patients. How might these findings and a new HHS initiative lower provider burden?
Cheryl A. Ferrier, MD, FACOG, highlights how “Femtech” tools like telehealth, remote patient monitoring, and patient portals can help moms during the “fourth trimester.”
Trust is fundamental in the physician-patient relationship, but studies show that up to 80 percent of patients have not been truthful with their physicians during their visits — but physicians can change this with a few tricks.
Robotic process automation (RPA) uses artificial intelligence to reduce administrative burden for physicians by automating repetitive tasks. The technology has the potential to revolutionize the healthcare industry. Stacy Lutz, Senior Vice President of Product Engineering at Privia Health, discusses how physicians can get started.
A recent study reveals emergency COVID-19 ICD-10 codes are not sensitive enough to catch all positive cases. What does this mean for physicians?
Pediatricians are the most important resource for parents who are concerned about their child’s mental and behavioral health, but data shows that there are significant care gaps between pediatricians and child psychiatrists. What small changes can pediatricians make to their practices to help address this?
Although healthcare mergers and acquisition (M&A) activity declined in the wake of COVID-19, experts predict a rebound is imminent. How might this slowdown highlight the need for greater “scale, coordination, and innovation” in the industry?
A new study by the American Medical Association (AMA) reveals that despite an almost 40 percent decrease in opioid prescriptions, overdose deaths are on the rise. What is contributing to this, and what changes can independent physicians expect to see in the future of substance abuse treatment?